⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Beren Therapeutics P.B.C. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Beren Therapeutics P.B.C.
↗Thousand Oaks, USA
Beren Therapeutics P.B.C. is a founder-led, clinical-stage biotechnology company operating as a public benefit corporation. The company focuses on the discovery, development, and commercialization of cyclodextrin-based therapeutics designed to address conditions characterized by defective cholesterol trafficking, such as Niemann-Pick disease type C (NPC).
Beren operates with a vertically integrated model, aiming to integrate the needs of patients, caregivers, clinicians, and health systems from the early stages of drug development. The company is the parent organization of Mandos LLC, which is the primary entity focused on the development of their lead candidate, adrabetadex.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Rare Disease / Neurodegenerative
SIZE & FINANCIALS
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Series C
Total Raised:$139M
Investors:Gaingels, Hercules Capital BDC, Narya, Stern Stewart Ventures, UTokyo Innovation Platform Company, JIC Venture Growth Investments
PIPELINE
Stage:Phase 3
Lead Drug Stage:NDA Submitted / Priority Review
Modalities:Cyclodextrin-based therapeutics
Trial Phases:Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Mandos LLC
Key Partnerships:Roquette (Strategic investment and innovation agreement for cyclodextrin technologies)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Jason Camm - Founder, Director, President, CEO
Aaron Ondrey - Chief Financial Officer
Alex Gold - Chief Medical Officer
Jennifer Spinella - Chief Regulatory Officer
LINKS
Website:berentx.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Beren Therapeutics P.B.C.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.